These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9117267)

  • 1. SV2proteoglycan: a potential synaptic vesicle transporter and nerve terminal extracellular matrix receptor.
    Carlson SS
    Perspect Dev Neurobiol; 1996; 3(4):373-86. PubMed ID: 9117267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proteins regulating neurotransmitter release of synaptic vesicles at nerve terminals].
    Cai Q; Lu PH; Sheng ZH
    Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):6-10. PubMed ID: 12778801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of nerve terminal populations: synaptic vesicle-associated proteins as markers for synaptic density in the rat neostriatum.
    Walaas SI; Jahn R; Greengard P
    Synapse; 1988; 2(5):516-20. PubMed ID: 3142072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vglut1 and ZnT3 co-targeting mechanisms regulate vesicular zinc stores in PC12 cells.
    Salazar G; Craige B; Love R; Kalman D; Faundez V
    J Cell Sci; 2005 May; 118(Pt 9):1911-21. PubMed ID: 15860731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles.
    Varoqui H; Erickson JD
    J Physiol Paris; 1998 Apr; 92(2):141-4. PubMed ID: 9782458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of synapsin I and II for neurotransmitter levels and vesicular storage in cholinergic, glutamatergic and GABAergic nerve terminals.
    Bogen IL; Haug KH; Roberg B; Fonnum F; Walaas SI
    Neurochem Int; 2009; 55(1-3):13-21. PubMed ID: 19428802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic vesicle fusion and synaptotagmin: 2B or not 2B?
    O'Connor V; Lee AG
    Nat Neurosci; 2002 Sep; 5(9):823-4. PubMed ID: 12196805
    [No Abstract]   [Full Text] [Related]  

  • 8. AP180 maintains the distribution of synaptic and vesicle proteins in the nerve terminal and indirectly regulates the efficacy of Ca2+-triggered exocytosis.
    Bao H; Daniels RW; MacLeod GT; Charlton MP; Atwood HL; Zhang B
    J Neurophysiol; 2005 Sep; 94(3):1888-903. PubMed ID: 15888532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recycling of synaptic vesicles in the nerve terminal].
    Tashiro T
    Tanpakushitsu Kakusan Koso; 1984 Nov; 29(12 Suppl):1046-55. PubMed ID: 6084850
    [No Abstract]   [Full Text] [Related]  

  • 10. Synaptotagmin I is necessary for compensatory synaptic vesicle endocytosis in vivo.
    Poskanzer KE; Marek KW; Sweeney ST; Davis GW
    Nature; 2003 Dec; 426(6966):559-63. PubMed ID: 14634669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic vesicle protein 2A: basic facts and role in synaptic function.
    Mendoza-Torreblanca JG; Vanoye-Carlo A; Phillips-Farfán BV; Carmona-Aparicio L; Gómez-Lira G
    Eur J Neurosci; 2013 Dec; 38(11):3529-39. PubMed ID: 24102679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synaptic vesicle protein SV2 is a novel type of transmembrane transporter.
    Feany MB; Lee S; Edwards RH; Buckley KM
    Cell; 1992 Sep; 70(5):861-7. PubMed ID: 1355409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicle pools, docking, priming, and release.
    Becherer U; Rettig J
    Cell Tissue Res; 2006 Nov; 326(2):393-407. PubMed ID: 16819626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal stromal tumors regularly express synaptic vesicle proteins: evidence of a neuroendocrine phenotype.
    Bümming P; Nilsson O; Ahlman H; Welbencer A; Andersson MK; Sjölund K; Nilsson B
    Endocr Relat Cancer; 2007 Sep; 14(3):853-63. PubMed ID: 17914114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gbetagamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition.
    Gerachshenko T; Blackmer T; Yoon EJ; Bartleson C; Hamm HE; Alford S
    Nat Neurosci; 2005 May; 8(5):597-605. PubMed ID: 15834421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of neurotransmitter release.
    Bennett MK
    Ann N Y Acad Sci; 1994 Sep; 733():256-65. PubMed ID: 7978875
    [No Abstract]   [Full Text] [Related]  

  • 17. A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals.
    Nishimune H; Sanes JR; Carlson SS
    Nature; 2004 Dec; 432(7017):580-7. PubMed ID: 15577901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synaptic vesicle protein SV2 is complexed with an alpha5-containing laminin on the nerve terminal surface.
    Son YJ; Scranton TW; Sunderland WJ; Baek SJ; Miner JH; Sanes JR; Carlson SS
    J Biol Chem; 2000 Jan; 275(1):451-60. PubMed ID: 10617638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The orphan transporter Rxt1/NTT4 (SLC6A17) functions as a synaptic vesicle amino acid transporter selective for proline, glycine, leucine, and alanine.
    Parra LA; Baust T; El Mestikawy S; Quiroz M; Hoffman B; Haflett JM; Yao JK; Torres GE
    Mol Pharmacol; 2008 Dec; 74(6):1521-32. PubMed ID: 18768736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve terminal components from normal and denervated Narcine electric organ.
    Hooper JE; Deutsch JW; Miljanich GP; Brasier AR; Kelly RB
    J Physiol (Paris); 1982; 78(4):443-53. PubMed ID: 7182490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.